Evidence map›Paper›PMID 40722736›Full record

ArticleBiomedicines2025

High Co-Expression of

Ping Yu, Chunliang Shang, Zhongyu Liu, Yuan Li, Tianhui He, Yuan Xue, Jian Lin, Yuan Li, Yu Wu, Tong Liu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ping YuDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Chunliang ShangDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Zhongyu LiuDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Yuan LiReproductive Medicine Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518000, China.
Tianhui HeDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0002-2835-0702
Yuan XueDepartment of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
Jian LinDepartment of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
Yuan LiDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Yu WuDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Tong LiuCenter of Basic Medical Research, Institute of Medical Innovation and Research, Cancer Center of Peking University Third Hospital, Peking University Third Hospital, Beijing 100191, China.
Hongyan GuoDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.

Funding

Clinical Medicine plus X Project of Peking University PKU2020LCXQ024National Natural Science Foundation of China 82073057National Natural Science Foundation of China 82372888
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ferroptosisGPAT4ovarian cancerplatinum resistanceSLC7A11

Identifiers

PMID40722736
PMCPMC12292186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.